Serum aminotransferase activity and mortality risk

Hepatology

Volumn 48, Issue 2, 2008, Pages 687-688

  Prati, Daniele ^a   Colli, Agostino ^a   Porretti, Laura ^b  

^a A MANZONI HOSPITAL   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; DIAGNOSTIC VALUE; HIGH RISK PATIENT; HUMAN; LETTER; LIVER DISEASE; MORTALITY; PREDICTION; PRIORITY JOURNAL; ROC CURVE; SCREENING TEST; SURVIVAL;

HUMANS; LIVER DISEASES; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TRANSAMINASES; UNITED STATES;

EID: 49649101833     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22361     Document Type: Letter

References (4)

1. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferse activity and mortality risk in a United States Community. HEPATOLOGY 2008;47:880-887.
2. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminorransferase levels. Ann Intern Med 2002; 137:1- 10.
3. Kim HC, Nam CM, Jee S, Han KH, Oh DK, Suh I. Normal serum aminotransferse concentration and risk of mortality from liver disease: prospective cohort study. BMJ 2004;328:983-986.
4. Know your ALT [press release]. Alexandria, VA: American Association for the Study of Liver Diseases; October 30, 2006. Available at: Https://www.aasld.org/eweb/docs/meetings/06annualmeeting/ pressadvisoryalt.pdf. Accessed April 11, 2008.